companydata.dkABBLO PHARMA ApS: Financial statements 2024
CVR: 34080534
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 854,994 and a net result of DKK 135,215 compared with DKK 107,380 the year before. That is an increase of 6.1% compared with the year before. Equity amounted to DKK -85,829. The company had 1 employee in the financial year.
- Gross Profit
- 854,994 kr.
- Profit/Loss
- 135,215 kr.
- Equity
- -85,829 kr.
- Total Assets
- 1,366,158 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 855 t. | 135 t. | -86 t. | 1 |
| 2023 | - | 806 t. | 107 t. | -221 t. | 1 |
| 2022 | - | 1.1 mio. | 301 t. | -328 t. | 1 |
| 2021 | - | 740 t. | 285 t. | -629 t. | 1 |
| 2020 | - | 376 t. | 214 t. | -914 t. | 1 |
How creditworthy is ABBLO PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
ABBLO PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 806,142, and the net result was DKK 107,380.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.